FNDC5 Attenuates Atherosclerotic Plaque Formation and Regulates PPARα/HO-1 in ApoE−/− Mice
Journal of Vascular Research · 2023
DOI: 10.1159/000531585 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Vascular Research, 2023. Verfasst von Bo Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Science, Guizhou Medical University, Guiyang, China. Hauptthemen laut MEDLINE: Plaque, Atherosclerotic, Atherosclerosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Introduction
This study attempted to observe the role of fibronectin type III domain-containing protein 5 (FNDC5) in atherosclerosis development and the underlying mechanism.
Methods
After being fed a high-fat diet (HFD), ApoE−/− mice were injected with saline, control adenovirus (Ad-vector), or FNDC5 overexpressing adenovirus (Ad-FNDC5). ApoE−/− mice fed with a chow diet were considered the control. After 12 weeks of treatment, the levels of serum high-density lipoprotein cholesterol (HDL-C), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglyceride (TG), and irisin were detected by commercial kits.
Results
Compared with the control, the serum TG, TC, and LDL-C levels, aortic plaque area, and weight were significantly increased, while serum HDL-C and irisin levels were reduced in HFD mice. Treating with Ad-FNDC5 could alleviate these changes in HFD mice and cause the activation of PPARα/HO-1 signaling in aortic tissue. After co-treating with GW6471, a PPARα antagonist, the effects of Ad-FNDC5 on the weight, serum LDL-C, TC, TG, and HDL-C levels, and aortic plaque of HFD mice were partly blocked.
Conclusion
Elevated FNDC5 has a delaying effect on atherosclerotic plaque formation, which may be related to the upregulation of PPARα/HO-1 signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medical Science, Guizhou Medical University, Guiyang, China.
- The First People's Hospital of Bijie City, Bijie, China.
- Department of Cardiology, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Zitieren
APA
Zhou, B., Wang, X., Wang, Y., & Liu, D. (2023). FNDC5 Attenuates Atherosclerotic Plaque Formation and Regulates PPARα/HO-1 in ApoE−/− Mice. Journal of Vascular Research. https://doi.org/10.1159/000531585
Vancouver
Zhou B, Wang X, Wang Y, Liu D. FNDC5 Attenuates Atherosclerotic Plaque Formation and Regulates PPARα/HO-1 in ApoE−/− Mice. Journal of Vascular Research. 2023. doi:10.1159/000531585
BibTeX
@article{Zhou2023,
author = {Zhou, Bo and Wang, Xiang and Wang, Yao and Liu, Danan},
title = {FNDC5 Attenuates Atherosclerotic Plaque Formation and Regulates PPARα/HO-1 in ApoE−/− Mice},
journal = {Journal of Vascular Research},
year = {2023},
doi = {10.1159/000531585}
}
EUVIMED